ARCCAres Capital Corporation
The Read
5% on Q2 results due to NAV declines, higher non-accruals, and sector-wide private credit concerns, aligning with a median historical macro move of ~1%.
The schedule
- Tue26Jan
Evaluation of ARCC's Q3 origination velocity and fee income off a discounted $17.80 base. Strong portfolio growth validating the direct lending thesis targets $18.60, while a stall in middle-market deployments pushes the valuation down to $17.10.
- Tue27Apr
Focus on the 2027 dividend declaration and Q4 credit quality from an $18.60 anchor. Confirmation of the base dividend alongside special distributions pushes the stock to $19.50, while rising corporate defaults trigger a $17.90 fallback.
- Tue27Jul
First quarter 2027 earnings assessed against the exceptionally weak Q1 2026 base, driving from a $19.50 anchor. Easy year-over-year comps and stable credit quality propel the stock to $20.25, while a failure to show operating leverage drags shares to $18.80.
Past
- Wed16Sep
Assessment of ARCC's net interest margin trajectory following the FOMC rate decision, anchoring from $18.50. A dovish stance compressing middle-market loan yields pushes shares down to a $17.80 fallback, while stabilization in long-end rates supports a $19.10 target.
- Tue28Jul
Actual outcome: Bear · $18.77 at outcome
Although Ares Capital met EPS estimates of $0.13, the stock faced downward pressure due to notable net asset value (NAV) declines and modestly higher non-accruals. A weakening investment market and broader negative sentiment around private credit weighed heavily on the BDC sector, driving shares down toward the bear floor as investors reacted to the constrained near-term upside.
Market evaluation of ARCC's Q2 earnings from a $19.25 base, following a weak Q1 where GAAP EPS dropped to $0.13. Favorable results driving shares to $19.65 would require core net investment income (NII) to comfortably cover the dividend. An adverse outcome to $18.50 will trigger if further unrealized losses drag down NAV.
- Thu30Apr
Actual outcome: Mixed · $18.99 at outcome
Ares Capital reported Q1 2026 GAAP EPS of $0.13, matching estimates, alongside core net investment income of $0.55 per share. The fundamental outcome was mixed; while core earnings slipped slightly below the dividend and net asset value declined modestly due to unrealized losses, the company offset this with strong portfolio activity and a low 1.2% non-accrual ratio. The stock remained flat as investors weighed the headline earnings pressure against the underlying stability of its loan portfolio and maintained dividend.
Ares Capital reported Q1 2026 GAAP EPS of $0.13, matching estimates, alongside core net investment income of $0.55 per share. The fundamental outcome was mixed; while core earnings slipped slightly below the dividend and net asset value declined modestly due to unrealized losses, the company offset this with strong portfolio activity and a low 1.2% non-accrual ratio. The stock remained flat as investors weighed the headline earnings pressure against the underlying stability of its loan portfolio and maintained dividend.
